Sonic Healthcare (ASX:SHL) Announces 1H FY2023 results; Declared interim dividend of AU 42 cents

On 16th February, 2023, Sonic Healthcare (ASX: SHL) announced 1H FY2023 results  and reported a net profit of AU$382 million, down 54% compared to the previous corresponding period.

• Earnings per share increased 52% versus H1 FY 2020 (pre-pandemic). 
• Base business revenue (excluding COVID testing) organic growth of 6% vs 1H FY2022 and 8% versus 1H FY2020 (constant currency, per working day). Growth gained momentum with January 2023 compared with January 2020 revenue increased 10%, mainly robust in the Australian Pathology division. 
• At present, the Company is progressing several acquisition and contract opportunities. 
• Gearing level close to historic lows, with ~AU$1.5 billion of available liquidity, well positioned to fund growth.
• Interim dividend increased by AU 2 cents to AU42 cents.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com